FDA 483 - Hemacare Corp - September 18, 2008

An FDA inspection of HemaCare Corp, a blood donor center in Los Angeles, CA, revealed significant deficiencies. Observations included inadequate training and experience for personnel, specifically the acting Donor Center Manager, and a lack of regular calibration for blood collection equipment. Additionally, the firm's standard operating procedures for autologous donations were found to be inadequate.